Intellectual Property in Facial Plastic and Reconstructive Surgery: The Importance and Process of Obtaining Intellectual Property Rights

被引：1

作者：

Razavi, Christopher R. ^{[1
,3
]}

Byrne, Patrick J. ^{[2
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Div Facial Plast & Reconstruct Surg, Portland, OR USA

[2] Cleveland Clin, Head & Neck Inst, Sect Facial Plast & Microvasc Surg, Cleveland, OH USA

[3] CHH 1-5th Floor,3303 S Bond Ave, Portland, OR 97239 USA

来源：

FACIAL PLASTIC SURGERY | 2023年 / 39卷 / 05期

关键词：

intellectual property; facial plastic and reconstructive surgery; innovation; FDA; medical devices;

D O I：

10.1055/a-2095-6367

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Understanding the purpose and process of obtaining intellectual property rights (IPR) is fundamental to health care innovation. Facial plastic and reconstructive surgeons are natural innovators; however, knowledge deficit in this space may hinder the ability to move ideas from the "bench to bedside." Here we provide an overview of IPR, outlining the steps necessary to obtain intellectual property protection in an academic setting while highlighting recent U.S. Food and Drug Administration (FDA) approvals pertaining to facial plastic and reconstructive surgery.

引用

页码：460 / 465

页数：6

共 38 条

[31] U.S. Food and Drug Administration, UPNEEQ OX HYDR OPHTH
[32] U.S. Food and Drug Administration, 2023, SOFWAVE SYST 510 K P
[33] U.S. Food and Drug Administration, 2023, STARPORE POL ENT SYN
[34] U.S. Food and Drug Administration, 2023, SUMM SAF EFF DAT SSE
[35] U.S. Food and Drug Administration, 2023, MET PAT SPEC TIT MES
[36] U.S. Food and Drug Administration, 2023, PREM APPR PMA HEM BE
[37] U.S. Patent and Trademark Office, TYP PAT
[38] US Food and Drug Administration, 2023, AI ME SYST 510 K PRE

← 1 2 3 4 →